QrumPharma Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

QrumPharma General Information

Description

Operator of a pharmaceutical company developing inhalation treatments for severe chronic and recurrent pulmonary infections. The company is developing a drug for the treatment of Nontuberculous Mycobacteria (NTM) and Tuberculosis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 215 Decatur Street
  • Doylestown, PA 18901
  • United States
Primary Industry
Drug Discovery
Acquirer
Corporate Office
  • 215 Decatur Street
  • Doylestown, PA 18901
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

QrumPharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore QrumPharma‘s full profile, request access.

Request a free trial

QrumPharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company developing inhalation treatments for severe chronic and recurrent pulmonary infecti
Drug Discovery
Doylestown, PA

London, United Kingdom
 

Arlington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

QrumPharma Competitors (36)

One of QrumPharma’s 36 competitors is Verona Pharma, a Corporate Backed or Acquired company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verona Pharma Corporate Backed or Acquired London, United Kingdom
Eloxx Pharmaceuticals Formerly VC-backed Arlington, MA
Avalyn Pharma Formerly VC-backed Boston, MA
Enterprise Therapeutics Venture Capital-Backed Brighton, United Kingdom
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 5 of 36 competitors. Get the full list »

QrumPharma Patents

QrumPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020123336-A1 Compositions of bedaquiline, combinations comprising them, processes for their preparation, uses and methods of treatment comprising them Inactive 13-Dec-2018
WO-2020040818-A1 Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them Inactive 23-Aug-2018
WO-2019110099-A1 Inhalable clofazimine formulation Inactive 06-Dec-2017 A61P31/06

QrumPharma FAQs

  • Where is QrumPharma headquartered?

    QrumPharma is headquartered in Doylestown, PA.

  • What industry is QrumPharma in?

    QrumPharma’s primary industry is Drug Discovery.

  • Is QrumPharma a private or public company?

    QrumPharma is a Private company.

  • What is the current valuation of QrumPharma?

    The current valuation of QrumPharma is .

  • What is QrumPharma’s current revenue?

    The current revenue for QrumPharma is .

  • Who are QrumPharma’s competitors?

    Verona Pharma, Eloxx Pharmaceuticals, Avalyn Pharma, Enterprise Therapeutics, and Sarepta Therapeutics are some of the 36 competitors of QrumPharma.

  • When was QrumPharma acquired?

    QrumPharma was acquired on 07-Dec-2020.

  • Who acquired QrumPharma?

    QrumPharma was acquired by MannKind.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process